Inicio › Cáncer de pulmón de células no pequeñas › Florida › St. Petersburg
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en St. Petersburg, FL
21 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de St. Petersburg y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- Saint Anthony's Hospital Cancer Care Center, St. Petersburg
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
ReclutandoFase 1/2
- Florida Cancer Specialists - NORTH - SCRI - PPDS, St. Petersburg
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 3
- Florida Cancer Specialists - NORTH - SCRI - PPDS, St. Petersburg
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- Moffitt Cancer Center at SouthShore, Ruskin · A 15 mi de distancia
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
ReclutandoFase 2
- Comprehensive Hematology Oncology /ID# 270422, St. Petersburg
- Florida Cancer Specialists - North /ID# 271995, St. Petersburg
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
ReclutandoFase 3
- Comprehensive Hematology Oncology, St. Petersburg
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
ReclutandoFase 3
- Florida Cancer Specialists & Research Institute - North, St. Petersburg
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- Florida Cancer Specialists, St. Petersburg
- Florida Cancer Specialists, St. Petersburg
- Florida Cancer Specialists, Bradenton · A 20 mi de distancia
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
ReclutandoFase 3
- Research Site, St. Petersburg
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ReclutandoFase 2
- Florida Cancer Specialists & Research Institute 1, St. Petersburg
Pan-tumor MRD Study
ReclutandoEstudio observacional
- Comprehensive Hematology Oncology (CHO), St. Petersburg
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
ReclutandoFase 3
- Florida Cancer Specialists North, St. Petersburg
- Comprehensive Hematology Oncology, St. Petersburg
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
ReclutandoFase 3
- Florida Cancer Specialists - North, St. Petersburg
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
ReclutandoFase 3
- Local Institution - 0695, St. Petersburg
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
ReclutandoFase 3
- Clinical Study Site, St. Petersburg
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
ReclutandoFase 2/3
- Local Institution - 007-922-D, Bradenton · A 20 mi de distancia
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- Comprehensive Hematology Oncology, St. Petersburg
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- Comprehensive Hematology Oncology, St. Petersburg
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
ReclutandoFase 3
- Research Site, St. Petersburg
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ReclutandoFase 1/2
- USOR Florida Cancer Specialists North, St. Petersburg
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Saint Anthony's Hospital Cancer Care Center, St. Petersburg
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en St. Petersburg
- Cáncer de seno11 estudios
- Sobrepeso8 estudios
- Obesidad8 estudios
- Fallo cardíaco8 estudios
- Cáncer del colon y del recto8 estudios
- Cáncer de pulmón7 estudios
- Cáncer de endometrio6 estudios
- Linfoma de Burkitt6 estudios
- Cáncer de ovario6 estudios
- Diabetes tipo 25 estudios
- Dermatitis atópica (eccema)5 estudios
- Enfermedad de obstrucción pulmonar crónica5 estudios
De ClinicalTrials.gov, datos obtenidos el 7 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.